Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1808-1818
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1808
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1808
Table 5 R0 resection rate of gastric cancer in patients after neoadjuvant chemotherapy and surgery versus upfront surgery
Ref. | R0 resection rate | P value | |
NAT | US | ||
Ahn et al[8], 2014 | 92.2% | ||
Biondi et al[9], 2018 | 82.9% | 83.6% | 0.449 |
Bracale et al[10], 2021 | NS | NS | |
Eom et al[11], 2018 | 97.7% | 97.7% | |
Feng et al[12], 2015 | 95% | 94.4% | |
Wang et al[13], 2021 | 84.6% | 56.7% | 0.029 |
Xue et al[14], 2018 | 100% | 96% | |
Kang et al[15], 2021 | NS | NS | |
Kano et al[16], 2019 | 100% | 100% | |
Lin et al[17], 2022 | 90.1% | ||
Marino et al[18], 2021 | NS | NS | |
Molina et al[19], 2013 | - | 80% | |
Pardo et al[20], 2020 | NS | NS | |
Wang et al[21], 2019 | 89.2% | 84.6% | > 0.05 |
Wang et al[22], 2021 | 96%1 | 89%1 | 0.061 |
Wu et al[23], 2019 | NS | NS | |
Xu et al[24], 2021 | 94.12% | 89.14% | 0.072 |
Zhao et al[25], 2017 | NS | NS |
- Citation: Fiflis S, Papakonstantinou M, Giakoustidis A, Christodoulidis G, Louri E, Papadopoulos VN, Giakoustidis D. Comparison between upfront surgery and neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A systematic review. World J Gastrointest Surg 2023; 15(8): 1808-1818
- URL: https://www.wjgnet.com/1948-9366/full/v15/i8/1808.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i8.1808